Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Grebely

Showing results (141-150 of 368) with videos related to

Pageof 37
Sort By:
The International Journal on Drug Policy|March 19, 2024
Vaccination coverage among people who inject drugs: A systematic reviewOlivia Price, Rosie Swanton, Jason Grebely, et al.
The Lancet. Gastroenterology & Hepatology|March 7, 2025
The urgent need for implementation science to achieve hepatitis C eliminationGuillaume Fontaine, Natalie Taylor, Julie Bruneau, et al.
The International Journal on Drug Policy|July 29, 2019
The prevalence of non-fatal overdose among people who inject drugs: A multi-stage systematic review and meta-analysisSamantha Colledge, Amy Peacock, Janni Leung, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 30, 2008
Primary drug resistance in antiretroviral-naïve injection drug usersHarout K Tossonian, Jesse D Raffa, Jason Grebely, et al.
The International Journal on Drug Policy|September 20, 2021
Reinfection following successful direct-acting antiviral therapy for HCV infection among people attending an inner-city community health centre in Victoria, CanadaMarion Selfridge, Evan B Cunningham, Tamara Barnett, et al.
The International Journal on Drug Policy|July 16, 2019
An intervention to improve HCV testing, linkage to care, and treatment among people who use drugs in Tehran, Iran: The ENHANCE studyMaryam Alavi, Hossein Poustchi, Shahin Merat, et al.
Antiviral Therapy|August 9, 2014
Naturally occurring dominant drug resistance mutations occur infrequently in the setting of recently acquired hepatitis CTanya L Applegate, Silvana Gaudieri, Anne Plauzolles, et al.
Plos One|December 4, 2015
Are Interferon-Free Direct-Acting Antivirals for the Treatment of HCV Enough to Control the Epidemic among People Who Inject Drugs?Viviane D Lima, Ignacio Rozada, Jason Grebely, et al.
The International Journal on Drug Policy|August 16, 2015
Assessment and delivery of treatment for hepatitis C virus infection in an opioid substitution treatment clinic with integrated peer-based support in Newcastle, AustraliaJulian Keats, Michelle Micallef, Jason Grebely, et al.
The International Journal on Drug Policy|November 27, 2018
Perceptions and self-reported competency related to testing, management and treatment of hepatitis C virus infection among physicians prescribing opioid agonist treatment: The C-SCOPE studyJason Grebely, Martine Drolet, Chizoba Nwankwo, et al.
Pageof 37

Showing results (141-150 of 368) with videos related to

Sort By:
Pageof 37
The International Journal on Drug Policy|March 19, 2024
Vaccination coverage among people who inject drugs: A systematic reviewOlivia Price, Rosie Swanton, Jason Grebely, et al.
The Lancet. Gastroenterology & Hepatology|March 7, 2025
The urgent need for implementation science to achieve hepatitis C eliminationGuillaume Fontaine, Natalie Taylor, Julie Bruneau, et al.
The International Journal on Drug Policy|July 29, 2019
The prevalence of non-fatal overdose among people who inject drugs: A multi-stage systematic review and meta-analysisSamantha Colledge, Amy Peacock, Janni Leung, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 30, 2008
Primary drug resistance in antiretroviral-naïve injection drug usersHarout K Tossonian, Jesse D Raffa, Jason Grebely, et al.
The International Journal on Drug Policy|September 20, 2021
Reinfection following successful direct-acting antiviral therapy for HCV infection among people attending an inner-city community health centre in Victoria, CanadaMarion Selfridge, Evan B Cunningham, Tamara Barnett, et al.
The International Journal on Drug Policy|July 16, 2019
An intervention to improve HCV testing, linkage to care, and treatment among people who use drugs in Tehran, Iran: The ENHANCE studyMaryam Alavi, Hossein Poustchi, Shahin Merat, et al.
Antiviral Therapy|August 9, 2014
Naturally occurring dominant drug resistance mutations occur infrequently in the setting of recently acquired hepatitis CTanya L Applegate, Silvana Gaudieri, Anne Plauzolles, et al.
Plos One|December 4, 2015
Are Interferon-Free Direct-Acting Antivirals for the Treatment of HCV Enough to Control the Epidemic among People Who Inject Drugs?Viviane D Lima, Ignacio Rozada, Jason Grebely, et al.
The International Journal on Drug Policy|August 16, 2015
Assessment and delivery of treatment for hepatitis C virus infection in an opioid substitution treatment clinic with integrated peer-based support in Newcastle, AustraliaJulian Keats, Michelle Micallef, Jason Grebely, et al.
The International Journal on Drug Policy|November 27, 2018
Perceptions and self-reported competency related to testing, management and treatment of hepatitis C virus infection among physicians prescribing opioid agonist treatment: The C-SCOPE studyJason Grebely, Martine Drolet, Chizoba Nwankwo, et al.
Pageof 37